Global Radiopharmaceutical Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Radiopharmaceutical competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.In 2024, global Radiopharmaceuticals production reached approximately 139.47 m units, with an average global market price of around US$ 68.49 perunit.The average gross profit margin of this product is 72%.The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours. Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
The global Radiopharmaceutical market size was estimated at USD 9552.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Radiopharmaceutical market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Radiopharmaceutical market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Radiopharmaceutical market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Radiopharmaceutical, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Radiopharmaceutical market size was estimated at USD 9552.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Radiopharmaceutical market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Radiopharmaceutical market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Radiopharmaceutical market.
Global Radiopharmaceutical Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Cardinal Health
- GE Healthcare
- Lantheus Medical Imaging
- Bayer
- Eli Lilly
- Bracco Imaging
- Curium Pharma
- Jubilant Pharmova
- Aurobindo Pharma
- Novartis
- Siemens
- NTP Radioisotopes
- ANSTO
- Polatom
- China Isotope & Radiation
- Dongcheng
- Seed Medical
Market Segmentation (by Type)
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
Market Segmentation (by Application)
- Hospital
- Inmaging Center
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Radiopharmaceutical Market
Overview of the regional outlook of the Radiopharmaceutical Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Radiopharmaceutical, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Radiopharmaceutical
1.2 Key Market Segments
1.2.1 Radiopharmaceutical Segment by Type
1.2.2 Radiopharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceutical Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Radiopharmaceutical Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radiopharmaceutical Product Life Cycle
3.3 Global Radiopharmaceutical Sales by Manufacturers (2020-2025)
3.4 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2020-2025)
3.5 Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radiopharmaceutical Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Radiopharmaceutical Market Competitive Situation and Trends
3.8.1 Radiopharmaceutical Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radiopharmaceutical Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceutical Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radiopharmaceutical Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Radiopharmaceutical Market
5.7 ESG Ratings of Leading Companies
6 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
6.3 Global Radiopharmaceutical Market Size by Type (2020-2025)
6.4 Global Radiopharmaceutical Price by Type (2020-2025)
7 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceutical Market Sales by Application (2020-2025)
7.3 Global Radiopharmaceutical Market Size (M USD) by Application (2020-2025)
7.4 Global Radiopharmaceutical Sales Growth Rate by Application (2020-2025)
8 RADIOPHARMACEUTICAL MARKET SALES BY REGION
8.1 Global Radiopharmaceutical Sales by Region
8.1.1 Global Radiopharmaceutical Sales by Region
8.1.2 Global Radiopharmaceutical Sales Market Share by Region
8.2 Global Radiopharmaceutical Market Size by Region
8.2.1 Global Radiopharmaceutical Market Size by Region
8.2.2 Global Radiopharmaceutical Market Size by Region
8.3 North America
8.3.1 North America Radiopharmaceutical Sales by Country
8.3.2 North America Radiopharmaceutical Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Radiopharmaceutical Sales by Country
8.4.2 Europe Radiopharmaceutical Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Radiopharmaceutical Sales by Region
8.5.2 Asia Pacific Radiopharmaceutical Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Radiopharmaceutical Sales by Country
8.6.2 South America Radiopharmaceutical Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Radiopharmaceutical Sales by Region
8.7.2 Middle East and Africa Radiopharmaceutical Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RADIOPHARMACEUTICAL MARKET PRODUCTION BY REGION
9.1 Global Production of Radiopharmaceutical by Region(2020-2025)
9.2 Global Radiopharmaceutical Revenue Market Share by Region (2020-2025)
9.3 Global Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Radiopharmaceutical Production
9.4.1 North America Radiopharmaceutical Production Growth Rate (2020-2025)
9.4.2 North America Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Radiopharmaceutical Production
9.5.1 Europe Radiopharmaceutical Production Growth Rate (2020-2025)
9.5.2 Europe Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Radiopharmaceutical Production (2020-2025)
9.6.1 Japan Radiopharmaceutical Production Growth Rate (2020-2025)
9.6.2 Japan Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Radiopharmaceutical Production (2020-2025)
9.7.1 China Radiopharmaceutical Production Growth Rate (2020-2025)
9.7.2 China Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Radiopharmaceutical Product Overview
10.1.3 Cardinal Health Radiopharmaceutical Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Radiopharmaceutical Product Overview
10.2.3 GE Healthcare Radiopharmaceutical Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Lantheus Medical Imaging
10.3.1 Lantheus Medical Imaging Basic Information
10.3.2 Lantheus Medical Imaging Radiopharmaceutical Product Overview
10.3.3 Lantheus Medical Imaging Radiopharmaceutical Product Market Performance
10.3.4 Lantheus Medical Imaging Business Overview
10.3.5 Lantheus Medical Imaging SWOT Analysis
10.3.6 Lantheus Medical Imaging Recent Developments
10.4 Bayer
10.4.1 Bayer Basic Information
10.4.2 Bayer Radiopharmaceutical Product Overview
10.4.3 Bayer Radiopharmaceutical Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 Eli Lilly
10.5.1 Eli Lilly Basic Information
10.5.2 Eli Lilly Radiopharmaceutical Product Overview
10.5.3 Eli Lilly Radiopharmaceutical Product Market Performance
10.5.4 Eli Lilly Business Overview
10.5.5 Eli Lilly Recent Developments
10.6 Bracco Imaging
10.6.1 Bracco Imaging Basic Information
10.6.2 Bracco Imaging Radiopharmaceutical Product Overview
10.6.3 Bracco Imaging Radiopharmaceutical Product Market Performance
10.6.4 Bracco Imaging Business Overview
10.6.5 Bracco Imaging Recent Developments
10.7 Curium Pharma
10.7.1 Curium Pharma Basic Information
10.7.2 Curium Pharma Radiopharmaceutical Product Overview
10.7.3 Curium Pharma Radiopharmaceutical Product Market Performance
10.7.4 Curium Pharma Business Overview
10.7.5 Curium Pharma Recent Developments
10.8 Jubilant Pharmova
10.8.1 Jubilant Pharmova Basic Information
10.8.2 Jubilant Pharmova Radiopharmaceutical Product Overview
10.8.3 Jubilant Pharmova Radiopharmaceutical Product Market Performance
10.8.4 Jubilant Pharmova Business Overview
10.8.5 Jubilant Pharmova Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Basic Information
10.9.2 Aurobindo Pharma Radiopharmaceutical Product Overview
10.9.3 Aurobindo Pharma Radiopharmaceutical Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 Novartis
10.10.1 Novartis Basic Information
10.10.2 Novartis Radiopharmaceutical Product Overview
10.10.3 Novartis Radiopharmaceutical Product Market Performance
10.10.4 Novartis Business Overview
10.10.5 Novartis Recent Developments
10.11 Siemens
10.11.1 Siemens Basic Information
10.11.2 Siemens Radiopharmaceutical Product Overview
10.11.3 Siemens Radiopharmaceutical Product Market Performance
10.11.4 Siemens Business Overview
10.11.5 Siemens Recent Developments
10.12 NTP Radioisotopes
10.12.1 NTP Radioisotopes Basic Information
10.12.2 NTP Radioisotopes Radiopharmaceutical Product Overview
10.12.3 NTP Radioisotopes Radiopharmaceutical Product Market Performance
10.12.4 NTP Radioisotopes Business Overview
10.12.5 NTP Radioisotopes Recent Developments
10.13 ANSTO
10.13.1 ANSTO Basic Information
10.13.2 ANSTO Radiopharmaceutical Product Overview
10.13.3 ANSTO Radiopharmaceutical Product Market Performance
10.13.4 ANSTO Business Overview
10.13.5 ANSTO Recent Developments
10.14 Polatom
10.14.1 Polatom Basic Information
10.14.2 Polatom Radiopharmaceutical Product Overview
10.14.3 Polatom Radiopharmaceutical Product Market Performance
10.14.4 Polatom Business Overview
10.14.5 Polatom Recent Developments
10.15 China Isotope and Radiation
10.15.1 China Isotope and Radiation Basic Information
10.15.2 China Isotope and Radiation Radiopharmaceutical Product Overview
10.15.3 China Isotope and Radiation Radiopharmaceutical Product Market Performance
10.15.4 China Isotope and Radiation Business Overview
10.15.5 China Isotope and Radiation Recent Developments
10.16 Dongcheng
10.16.1 Dongcheng Basic Information
10.16.2 Dongcheng Radiopharmaceutical Product Overview
10.16.3 Dongcheng Radiopharmaceutical Product Market Performance
10.16.4 Dongcheng Business Overview
10.16.5 Dongcheng Recent Developments
10.17 Seed Medical
10.17.1 Seed Medical Basic Information
10.17.2 Seed Medical Radiopharmaceutical Product Overview
10.17.3 Seed Medical Radiopharmaceutical Product Market Performance
10.17.4 Seed Medical Business Overview
10.17.5 Seed Medical Recent Developments
11 RADIOPHARMACEUTICAL MARKET FORECAST BY REGION
11.1 Global Radiopharmaceutical Market Size Forecast
11.2 Global Radiopharmaceutical Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Radiopharmaceutical Market Size Forecast by Country
11.2.3 Asia Pacific Radiopharmaceutical Market Size Forecast by Region
11.2.4 South America Radiopharmaceutical Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Radiopharmaceutical by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Radiopharmaceutical Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Radiopharmaceutical by Type (2026-2035)
12.1.2 Global Radiopharmaceutical Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Radiopharmaceutical by Type (2026-2035)
12.2 Global Radiopharmaceutical Market Forecast by Application (2026-2035)
12.2.1 Global Radiopharmaceutical Sales (K MT) Forecast by Application
12.2.2 Global Radiopharmaceutical Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Radiopharmaceutical
1.2 Key Market Segments
1.2.1 Radiopharmaceutical Segment by Type
1.2.2 Radiopharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceutical Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Radiopharmaceutical Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radiopharmaceutical Product Life Cycle
3.3 Global Radiopharmaceutical Sales by Manufacturers (2020-2025)
3.4 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2020-2025)
3.5 Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radiopharmaceutical Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Radiopharmaceutical Market Competitive Situation and Trends
3.8.1 Radiopharmaceutical Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radiopharmaceutical Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceutical Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radiopharmaceutical Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Radiopharmaceutical Market
5.7 ESG Ratings of Leading Companies
6 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
6.3 Global Radiopharmaceutical Market Size by Type (2020-2025)
6.4 Global Radiopharmaceutical Price by Type (2020-2025)
7 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceutical Market Sales by Application (2020-2025)
7.3 Global Radiopharmaceutical Market Size (M USD) by Application (2020-2025)
7.4 Global Radiopharmaceutical Sales Growth Rate by Application (2020-2025)
8 RADIOPHARMACEUTICAL MARKET SALES BY REGION
8.1 Global Radiopharmaceutical Sales by Region
8.1.1 Global Radiopharmaceutical Sales by Region
8.1.2 Global Radiopharmaceutical Sales Market Share by Region
8.2 Global Radiopharmaceutical Market Size by Region
8.2.1 Global Radiopharmaceutical Market Size by Region
8.2.2 Global Radiopharmaceutical Market Size by Region
8.3 North America
8.3.1 North America Radiopharmaceutical Sales by Country
8.3.2 North America Radiopharmaceutical Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Radiopharmaceutical Sales by Country
8.4.2 Europe Radiopharmaceutical Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Radiopharmaceutical Sales by Region
8.5.2 Asia Pacific Radiopharmaceutical Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Radiopharmaceutical Sales by Country
8.6.2 South America Radiopharmaceutical Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Radiopharmaceutical Sales by Region
8.7.2 Middle East and Africa Radiopharmaceutical Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RADIOPHARMACEUTICAL MARKET PRODUCTION BY REGION
9.1 Global Production of Radiopharmaceutical by Region(2020-2025)
9.2 Global Radiopharmaceutical Revenue Market Share by Region (2020-2025)
9.3 Global Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Radiopharmaceutical Production
9.4.1 North America Radiopharmaceutical Production Growth Rate (2020-2025)
9.4.2 North America Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Radiopharmaceutical Production
9.5.1 Europe Radiopharmaceutical Production Growth Rate (2020-2025)
9.5.2 Europe Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Radiopharmaceutical Production (2020-2025)
9.6.1 Japan Radiopharmaceutical Production Growth Rate (2020-2025)
9.6.2 Japan Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Radiopharmaceutical Production (2020-2025)
9.7.1 China Radiopharmaceutical Production Growth Rate (2020-2025)
9.7.2 China Radiopharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Radiopharmaceutical Product Overview
10.1.3 Cardinal Health Radiopharmaceutical Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Radiopharmaceutical Product Overview
10.2.3 GE Healthcare Radiopharmaceutical Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Lantheus Medical Imaging
10.3.1 Lantheus Medical Imaging Basic Information
10.3.2 Lantheus Medical Imaging Radiopharmaceutical Product Overview
10.3.3 Lantheus Medical Imaging Radiopharmaceutical Product Market Performance
10.3.4 Lantheus Medical Imaging Business Overview
10.3.5 Lantheus Medical Imaging SWOT Analysis
10.3.6 Lantheus Medical Imaging Recent Developments
10.4 Bayer
10.4.1 Bayer Basic Information
10.4.2 Bayer Radiopharmaceutical Product Overview
10.4.3 Bayer Radiopharmaceutical Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 Eli Lilly
10.5.1 Eli Lilly Basic Information
10.5.2 Eli Lilly Radiopharmaceutical Product Overview
10.5.3 Eli Lilly Radiopharmaceutical Product Market Performance
10.5.4 Eli Lilly Business Overview
10.5.5 Eli Lilly Recent Developments
10.6 Bracco Imaging
10.6.1 Bracco Imaging Basic Information
10.6.2 Bracco Imaging Radiopharmaceutical Product Overview
10.6.3 Bracco Imaging Radiopharmaceutical Product Market Performance
10.6.4 Bracco Imaging Business Overview
10.6.5 Bracco Imaging Recent Developments
10.7 Curium Pharma
10.7.1 Curium Pharma Basic Information
10.7.2 Curium Pharma Radiopharmaceutical Product Overview
10.7.3 Curium Pharma Radiopharmaceutical Product Market Performance
10.7.4 Curium Pharma Business Overview
10.7.5 Curium Pharma Recent Developments
10.8 Jubilant Pharmova
10.8.1 Jubilant Pharmova Basic Information
10.8.2 Jubilant Pharmova Radiopharmaceutical Product Overview
10.8.3 Jubilant Pharmova Radiopharmaceutical Product Market Performance
10.8.4 Jubilant Pharmova Business Overview
10.8.5 Jubilant Pharmova Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Basic Information
10.9.2 Aurobindo Pharma Radiopharmaceutical Product Overview
10.9.3 Aurobindo Pharma Radiopharmaceutical Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 Novartis
10.10.1 Novartis Basic Information
10.10.2 Novartis Radiopharmaceutical Product Overview
10.10.3 Novartis Radiopharmaceutical Product Market Performance
10.10.4 Novartis Business Overview
10.10.5 Novartis Recent Developments
10.11 Siemens
10.11.1 Siemens Basic Information
10.11.2 Siemens Radiopharmaceutical Product Overview
10.11.3 Siemens Radiopharmaceutical Product Market Performance
10.11.4 Siemens Business Overview
10.11.5 Siemens Recent Developments
10.12 NTP Radioisotopes
10.12.1 NTP Radioisotopes Basic Information
10.12.2 NTP Radioisotopes Radiopharmaceutical Product Overview
10.12.3 NTP Radioisotopes Radiopharmaceutical Product Market Performance
10.12.4 NTP Radioisotopes Business Overview
10.12.5 NTP Radioisotopes Recent Developments
10.13 ANSTO
10.13.1 ANSTO Basic Information
10.13.2 ANSTO Radiopharmaceutical Product Overview
10.13.3 ANSTO Radiopharmaceutical Product Market Performance
10.13.4 ANSTO Business Overview
10.13.5 ANSTO Recent Developments
10.14 Polatom
10.14.1 Polatom Basic Information
10.14.2 Polatom Radiopharmaceutical Product Overview
10.14.3 Polatom Radiopharmaceutical Product Market Performance
10.14.4 Polatom Business Overview
10.14.5 Polatom Recent Developments
10.15 China Isotope and Radiation
10.15.1 China Isotope and Radiation Basic Information
10.15.2 China Isotope and Radiation Radiopharmaceutical Product Overview
10.15.3 China Isotope and Radiation Radiopharmaceutical Product Market Performance
10.15.4 China Isotope and Radiation Business Overview
10.15.5 China Isotope and Radiation Recent Developments
10.16 Dongcheng
10.16.1 Dongcheng Basic Information
10.16.2 Dongcheng Radiopharmaceutical Product Overview
10.16.3 Dongcheng Radiopharmaceutical Product Market Performance
10.16.4 Dongcheng Business Overview
10.16.5 Dongcheng Recent Developments
10.17 Seed Medical
10.17.1 Seed Medical Basic Information
10.17.2 Seed Medical Radiopharmaceutical Product Overview
10.17.3 Seed Medical Radiopharmaceutical Product Market Performance
10.17.4 Seed Medical Business Overview
10.17.5 Seed Medical Recent Developments
11 RADIOPHARMACEUTICAL MARKET FORECAST BY REGION
11.1 Global Radiopharmaceutical Market Size Forecast
11.2 Global Radiopharmaceutical Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Radiopharmaceutical Market Size Forecast by Country
11.2.3 Asia Pacific Radiopharmaceutical Market Size Forecast by Region
11.2.4 South America Radiopharmaceutical Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Radiopharmaceutical by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Radiopharmaceutical Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Radiopharmaceutical by Type (2026-2035)
12.1.2 Global Radiopharmaceutical Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Radiopharmaceutical by Type (2026-2035)
12.2 Global Radiopharmaceutical Market Forecast by Application (2026-2035)
12.2.1 Global Radiopharmaceutical Sales (K MT) Forecast by Application
12.2.2 Global Radiopharmaceutical Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Radiopharmaceutical Market Size by Type (M USD)
Table 4. Global Radiopharmaceutical Market Size by Application
Table 5. Radiopharmaceutical Market Size Comparison by Region (M USD)
Table 6. Global Radiopharmaceutical Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceutical Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Radiopharmaceutical Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Radiopharmaceutical Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2025)
Table 11. Global Market Radiopharmaceutical Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceutical Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Radiopharmaceutical Sales by Type (K MT)
Table 27. Global Radiopharmaceutical Market Size by Type (M USD)
Table 28. Global Radiopharmaceutical Sales (K MT) by Type (2020-2025)
Table 29. Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 30. Global Radiopharmaceutical Market Size (M USD) by Type (2020-2025)
Table 31. Global Radiopharmaceutical Market Share by Type (2020-2025)
Table 32. Global Radiopharmaceutical Price (USD/KG) by Type (2020-2025)
Table 33. Global Radiopharmaceutical Sales (K MT) by Application
Table 34. Global Radiopharmaceutical Market Size by Application
Table 35. Global Radiopharmaceutical Sales by Application (2020-2025) & (K MT)
Table 36. Global Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 37. Global Radiopharmaceutical Market Size by Application (2020-2025) & (M USD)
Table 38. Global Radiopharmaceutical Market Share by Application (2020-2025)
Table 39. Global Radiopharmaceutical Sales Growth Rate by Application (2020-2025)
Table 40. Global Radiopharmaceutical Sales by Region (2020-2025) & (K MT)
Table 41. Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
Table 42. Global Radiopharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 43. Global Radiopharmaceutical Market Size by Region (2020-2025)
Table 44. North America Radiopharmaceutical Sales by Country (2020-2025) & (K MT)
Table 45. North America Radiopharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Radiopharmaceutical Sales by Country (2020-2025) & (K MT)
Table 47. Europe Radiopharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Radiopharmaceutical Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Radiopharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 50. South America Radiopharmaceutical Sales by Country (2020-2025) & (K MT)
Table 51. South America Radiopharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Radiopharmaceutical Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Radiopharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 54. Global Radiopharmaceutical Production (K MT) by Region(2020-2025)
Table 55. Global Radiopharmaceutical Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Radiopharmaceutical Revenue Market Share by Region (2020-2025)
Table 57. Global Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cardinal Health Basic Information
Table 63. Cardinal Health Radiopharmaceutical Product Overview
Table 64. Cardinal Health Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. GE Healthcare Basic Information
Table 69. GE Healthcare Radiopharmaceutical Product Overview
Table 70. GE Healthcare Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare SWOT Analysis
Table 73. GE Healthcare Recent Developments
Table 74. Lantheus Medical Imaging Basic Information
Table 75. Lantheus Medical Imaging Radiopharmaceutical Product Overview
Table 76. Lantheus Medical Imaging Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Lantheus Medical Imaging Business Overview
Table 78. Lantheus Medical Imaging SWOT Analysis
Table 79. Lantheus Medical Imaging Recent Developments
Table 80. Bayer Basic Information
Table 81. Bayer Radiopharmaceutical Product Overview
Table 82. Bayer Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Business Overview
Table 84. Bayer Recent Developments
Table 85. Eli Lilly Basic Information
Table 86. Eli Lilly Radiopharmaceutical Product Overview
Table 87. Eli Lilly Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Recent Developments
Table 90. Bracco Imaging Basic Information
Table 91. Bracco Imaging Radiopharmaceutical Product Overview
Table 92. Bracco Imaging Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bracco Imaging Business Overview
Table 94. Bracco Imaging Recent Developments
Table 95. Curium Pharma Basic Information
Table 96. Curium Pharma Radiopharmaceutical Product Overview
Table 97. Curium Pharma Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Curium Pharma Business Overview
Table 99. Curium Pharma Recent Developments
Table 100. Jubilant Pharmova Basic Information
Table 101. Jubilant Pharmova Radiopharmaceutical Product Overview
Table 102. Jubilant Pharmova Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Jubilant Pharmova Business Overview
Table 104. Jubilant Pharmova Recent Developments
Table 105. Aurobindo Pharma Basic Information
Table 106. Aurobindo Pharma Radiopharmaceutical Product Overview
Table 107. Aurobindo Pharma Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Recent Developments
Table 110. Novartis Basic Information
Table 111. Novartis Radiopharmaceutical Product Overview
Table 112. Novartis Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Novartis Business Overview
Table 114. Novartis Recent Developments
Table 115. Siemens Basic Information
Table 116. Siemens Radiopharmaceutical Product Overview
Table 117. Siemens Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Siemens Business Overview
Table 119. Siemens Recent Developments
Table 120. NTP Radioisotopes Basic Information
Table 121. NTP Radioisotopes Radiopharmaceutical Product Overview
Table 122. NTP Radioisotopes Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. NTP Radioisotopes Business Overview
Table 124. NTP Radioisotopes Recent Developments
Table 125. ANSTO Basic Information
Table 126. ANSTO Radiopharmaceutical Product Overview
Table 127. ANSTO Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. ANSTO Business Overview
Table 129. ANSTO Recent Developments
Table 130. Polatom Basic Information
Table 131. Polatom Radiopharmaceutical Product Overview
Table 132. Polatom Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Polatom Business Overview
Table 134. Polatom Recent Developments
Table 135. China Isotope and Radiation Basic Information
Table 136. China Isotope and Radiation Radiopharmaceutical Product Overview
Table 137. China Isotope and Radiation Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. China Isotope and Radiation Business Overview
Table 139. China Isotope and Radiation Recent Developments
Table 140. Dongcheng Basic Information
Table 141. Dongcheng Radiopharmaceutical Product Overview
Table 142. Dongcheng Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Dongcheng Business Overview
Table 144. Dongcheng Recent Developments
Table 145. Seed Medical Basic Information
Table 146. Seed Medical Radiopharmaceutical Product Overview
Table 147. Seed Medical Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Seed Medical Business Overview
Table 149. Seed Medical Recent Developments
Table 150. Global Radiopharmaceutical Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Radiopharmaceutical Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Radiopharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Radiopharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Radiopharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Radiopharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Radiopharmaceutical Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Radiopharmaceutical Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Radiopharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Radiopharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Radiopharmaceutical Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Radiopharmaceutical Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Radiopharmaceutical Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Radiopharmaceutical Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Radiopharmaceutical Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Radiopharmaceutical Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Radiopharmaceutical Market Size by Type (M USD)
Table 4. Global Radiopharmaceutical Market Size by Application
Table 5. Radiopharmaceutical Market Size Comparison by Region (M USD)
Table 6. Global Radiopharmaceutical Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceutical Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Radiopharmaceutical Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Radiopharmaceutical Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2025)
Table 11. Global Market Radiopharmaceutical Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceutical Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Radiopharmaceutical Sales by Type (K MT)
Table 27. Global Radiopharmaceutical Market Size by Type (M USD)
Table 28. Global Radiopharmaceutical Sales (K MT) by Type (2020-2025)
Table 29. Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 30. Global Radiopharmaceutical Market Size (M USD) by Type (2020-2025)
Table 31. Global Radiopharmaceutical Market Share by Type (2020-2025)
Table 32. Global Radiopharmaceutical Price (USD/KG) by Type (2020-2025)
Table 33. Global Radiopharmaceutical Sales (K MT) by Application
Table 34. Global Radiopharmaceutical Market Size by Application
Table 35. Global Radiopharmaceutical Sales by Application (2020-2025) & (K MT)
Table 36. Global Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 37. Global Radiopharmaceutical Market Size by Application (2020-2025) & (M USD)
Table 38. Global Radiopharmaceutical Market Share by Application (2020-2025)
Table 39. Global Radiopharmaceutical Sales Growth Rate by Application (2020-2025)
Table 40. Global Radiopharmaceutical Sales by Region (2020-2025) & (K MT)
Table 41. Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
Table 42. Global Radiopharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 43. Global Radiopharmaceutical Market Size by Region (2020-2025)
Table 44. North America Radiopharmaceutical Sales by Country (2020-2025) & (K MT)
Table 45. North America Radiopharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Radiopharmaceutical Sales by Country (2020-2025) & (K MT)
Table 47. Europe Radiopharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Radiopharmaceutical Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Radiopharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 50. South America Radiopharmaceutical Sales by Country (2020-2025) & (K MT)
Table 51. South America Radiopharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Radiopharmaceutical Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Radiopharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 54. Global Radiopharmaceutical Production (K MT) by Region(2020-2025)
Table 55. Global Radiopharmaceutical Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Radiopharmaceutical Revenue Market Share by Region (2020-2025)
Table 57. Global Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Radiopharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cardinal Health Basic Information
Table 63. Cardinal Health Radiopharmaceutical Product Overview
Table 64. Cardinal Health Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. GE Healthcare Basic Information
Table 69. GE Healthcare Radiopharmaceutical Product Overview
Table 70. GE Healthcare Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare SWOT Analysis
Table 73. GE Healthcare Recent Developments
Table 74. Lantheus Medical Imaging Basic Information
Table 75. Lantheus Medical Imaging Radiopharmaceutical Product Overview
Table 76. Lantheus Medical Imaging Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Lantheus Medical Imaging Business Overview
Table 78. Lantheus Medical Imaging SWOT Analysis
Table 79. Lantheus Medical Imaging Recent Developments
Table 80. Bayer Basic Information
Table 81. Bayer Radiopharmaceutical Product Overview
Table 82. Bayer Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Business Overview
Table 84. Bayer Recent Developments
Table 85. Eli Lilly Basic Information
Table 86. Eli Lilly Radiopharmaceutical Product Overview
Table 87. Eli Lilly Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Recent Developments
Table 90. Bracco Imaging Basic Information
Table 91. Bracco Imaging Radiopharmaceutical Product Overview
Table 92. Bracco Imaging Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bracco Imaging Business Overview
Table 94. Bracco Imaging Recent Developments
Table 95. Curium Pharma Basic Information
Table 96. Curium Pharma Radiopharmaceutical Product Overview
Table 97. Curium Pharma Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Curium Pharma Business Overview
Table 99. Curium Pharma Recent Developments
Table 100. Jubilant Pharmova Basic Information
Table 101. Jubilant Pharmova Radiopharmaceutical Product Overview
Table 102. Jubilant Pharmova Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Jubilant Pharmova Business Overview
Table 104. Jubilant Pharmova Recent Developments
Table 105. Aurobindo Pharma Basic Information
Table 106. Aurobindo Pharma Radiopharmaceutical Product Overview
Table 107. Aurobindo Pharma Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Recent Developments
Table 110. Novartis Basic Information
Table 111. Novartis Radiopharmaceutical Product Overview
Table 112. Novartis Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Novartis Business Overview
Table 114. Novartis Recent Developments
Table 115. Siemens Basic Information
Table 116. Siemens Radiopharmaceutical Product Overview
Table 117. Siemens Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Siemens Business Overview
Table 119. Siemens Recent Developments
Table 120. NTP Radioisotopes Basic Information
Table 121. NTP Radioisotopes Radiopharmaceutical Product Overview
Table 122. NTP Radioisotopes Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. NTP Radioisotopes Business Overview
Table 124. NTP Radioisotopes Recent Developments
Table 125. ANSTO Basic Information
Table 126. ANSTO Radiopharmaceutical Product Overview
Table 127. ANSTO Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. ANSTO Business Overview
Table 129. ANSTO Recent Developments
Table 130. Polatom Basic Information
Table 131. Polatom Radiopharmaceutical Product Overview
Table 132. Polatom Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Polatom Business Overview
Table 134. Polatom Recent Developments
Table 135. China Isotope and Radiation Basic Information
Table 136. China Isotope and Radiation Radiopharmaceutical Product Overview
Table 137. China Isotope and Radiation Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. China Isotope and Radiation Business Overview
Table 139. China Isotope and Radiation Recent Developments
Table 140. Dongcheng Basic Information
Table 141. Dongcheng Radiopharmaceutical Product Overview
Table 142. Dongcheng Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Dongcheng Business Overview
Table 144. Dongcheng Recent Developments
Table 145. Seed Medical Basic Information
Table 146. Seed Medical Radiopharmaceutical Product Overview
Table 147. Seed Medical Radiopharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Seed Medical Business Overview
Table 149. Seed Medical Recent Developments
Table 150. Global Radiopharmaceutical Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Radiopharmaceutical Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Radiopharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Radiopharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Radiopharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Radiopharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Radiopharmaceutical Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Radiopharmaceutical Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Radiopharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Radiopharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Radiopharmaceutical Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Radiopharmaceutical Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Radiopharmaceutical Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Radiopharmaceutical Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Radiopharmaceutical Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Radiopharmaceutical Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radiopharmaceutical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceutical Market Size (M USD), 2025-2035
Figure 5. Global Radiopharmaceutical Market Size (M USD) (2020-2035)
Figure 6. Global Radiopharmaceutical Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceutical Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radiopharmaceutical Product Life Cycle
Figure 13. Radiopharmaceutical Sales Share by Manufacturers in 2025
Figure 14. Global Radiopharmaceutical Revenue Share by Manufacturers in 2025
Figure 15. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Radiopharmaceutical Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceutical Revenue in 2025
Figure 18. Industry Chain Map of Radiopharmaceutical
Figure 19. Global Radiopharmaceutical Market PEST Analysis
Figure 20. Global Radiopharmaceutical Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Radiopharmaceutical Market Share by Type
Figure 27. Sales Market Share of Radiopharmaceutical by Type (2020-2025)
Figure 28. Sales Market Share of Radiopharmaceutical by Type in 2025
Figure 29. Market Share of Radiopharmaceutical by Type (2020-2025)
Figure 30. Market Share of Radiopharmaceutical by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Radiopharmaceutical Market Share by Application
Figure 33. Global Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 34. Global Radiopharmaceutical Sales Market Share by Application in 2025
Figure 35. Global Radiopharmaceutical Market Share by Application (2020-2025)
Figure 36. Global Radiopharmaceutical Market Share by Application in 2025
Figure 37. Global Radiopharmaceutical Sales Growth Rate by Application (2020-2025)
Figure 38. Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
Figure 39. Global Radiopharmaceutical Market Size by Region (2020-2025)
Figure 40. North America Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Radiopharmaceutical Sales Market Share by Country in 2024
Figure 43. North America Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Radiopharmaceutical Market Size by Country in 2024
Figure 45. U.S. Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Radiopharmaceutical Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Radiopharmaceutical Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Radiopharmaceutical Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Radiopharmaceutical Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Radiopharmaceutical Sales Market Share by Country in 2024
Figure 53. Europe Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Radiopharmaceutical Market Size by Country in 2024
Figure 55. Germany Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Radiopharmaceutical Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Radiopharmaceutical Sales Market Share by Region in 2024
Figure 67. Asia Pacific Radiopharmaceutical Market Size by Region in 2024
Figure 68. China Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Radiopharmaceutical Sales and Growth Rate (K MT)
Figure 79. South America Radiopharmaceutical Sales Market Share by Country in 2024
Figure 80. South America Radiopharmaceutical Market Size and Growth Rate (M USD)
Figure 81. South America Radiopharmaceutical Market Size by Country in 2024
Figure 82. Brazil Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Radiopharmaceutical Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Radiopharmaceutical Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Radiopharmaceutical Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Radiopharmaceutical Market Size by Region in 2024
Figure 92. Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Radiopharmaceutical Production Market Share by Region (2020-2025)
Figure 103. North America Radiopharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Radiopharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Radiopharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 106. China Radiopharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Radiopharmaceutical Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Radiopharmaceutical Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Radiopharmaceutical Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Radiopharmaceutical Market Share Forecast by Type (2026-2035)
Figure 111. Global Radiopharmaceutical Sales Forecast by Application (2026-2035)
Figure 112. Global Radiopharmaceutical Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Radiopharmaceutical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceutical Market Size (M USD), 2025-2035
Figure 5. Global Radiopharmaceutical Market Size (M USD) (2020-2035)
Figure 6. Global Radiopharmaceutical Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceutical Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radiopharmaceutical Product Life Cycle
Figure 13. Radiopharmaceutical Sales Share by Manufacturers in 2025
Figure 14. Global Radiopharmaceutical Revenue Share by Manufacturers in 2025
Figure 15. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Radiopharmaceutical Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceutical Revenue in 2025
Figure 18. Industry Chain Map of Radiopharmaceutical
Figure 19. Global Radiopharmaceutical Market PEST Analysis
Figure 20. Global Radiopharmaceutical Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Radiopharmaceutical Market Share by Type
Figure 27. Sales Market Share of Radiopharmaceutical by Type (2020-2025)
Figure 28. Sales Market Share of Radiopharmaceutical by Type in 2025
Figure 29. Market Share of Radiopharmaceutical by Type (2020-2025)
Figure 30. Market Share of Radiopharmaceutical by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Radiopharmaceutical Market Share by Application
Figure 33. Global Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 34. Global Radiopharmaceutical Sales Market Share by Application in 2025
Figure 35. Global Radiopharmaceutical Market Share by Application (2020-2025)
Figure 36. Global Radiopharmaceutical Market Share by Application in 2025
Figure 37. Global Radiopharmaceutical Sales Growth Rate by Application (2020-2025)
Figure 38. Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
Figure 39. Global Radiopharmaceutical Market Size by Region (2020-2025)
Figure 40. North America Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Radiopharmaceutical Sales Market Share by Country in 2024
Figure 43. North America Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Radiopharmaceutical Market Size by Country in 2024
Figure 45. U.S. Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Radiopharmaceutical Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Radiopharmaceutical Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Radiopharmaceutical Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Radiopharmaceutical Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Radiopharmaceutical Sales Market Share by Country in 2024
Figure 53. Europe Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Radiopharmaceutical Market Size by Country in 2024
Figure 55. Germany Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Radiopharmaceutical Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Radiopharmaceutical Sales Market Share by Region in 2024
Figure 67. Asia Pacific Radiopharmaceutical Market Size by Region in 2024
Figure 68. China Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Radiopharmaceutical Sales and Growth Rate (K MT)
Figure 79. South America Radiopharmaceutical Sales Market Share by Country in 2024
Figure 80. South America Radiopharmaceutical Market Size and Growth Rate (M USD)
Figure 81. South America Radiopharmaceutical Market Size by Country in 2024
Figure 82. Brazil Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Radiopharmaceutical Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Radiopharmaceutical Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Radiopharmaceutical Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Radiopharmaceutical Market Size by Region in 2024
Figure 92. Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Radiopharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Radiopharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Radiopharmaceutical Production Market Share by Region (2020-2025)
Figure 103. North America Radiopharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Radiopharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Radiopharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 106. China Radiopharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Radiopharmaceutical Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Radiopharmaceutical Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Radiopharmaceutical Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Radiopharmaceutical Market Share Forecast by Type (2026-2035)
Figure 111. Global Radiopharmaceutical Sales Forecast by Application (2026-2035)
Figure 112. Global Radiopharmaceutical Market Share Forecast by Application (2026-2035)
More Publications
Global Enzyme Inhibitor Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
141 pages
Global Medical Grade Chitosan Market Research Report 2026(Status and Outlook)
US$ 2,980.00
March 2026
149 pages
Global Morpholine Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
134 pages
Global Plasminogen Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
112 pages
Global Contact Lens Solution Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
154 pages
